Report cover image

UAE Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring, Surgical Devices), By End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), And Segment Forecasts, 2025 - 2033

Published Aug 19, 2025
Length 150 Pages
SKU # GV20399996

Description

UAE Cardiovascular Devices Market Summary

The UAE cardiovascular devices market size was estimated at USD 247.90 million in 2024 and is projected to reach USD 410.52 million by 2033, growing at a CAGR of 5.75% from 2025 to 2033. Increased incidence of cardiovascular disease is one of the key aspects driving the market's growth.

According to an article published by the American Heart Association, Inc. in November 2024, in the UAE, cardiovascular diseases (CVDs) represent the primary health challenge, being responsible for approximately 36.7% of all fatalities, nearly double the proportion of deaths linked to cancer. This high disease burden underscores the urgent need for advanced diagnostic, monitoring, and treatment solutions, thereby driving demand for cardiovascular devices in the country. The growing prevalence of risk factors such as obesity, diabetes, and sedentary lifestyles further amplifies the requirement for innovative medical technologies, positioning the UAE cardiovascular devices market for continued growth.

Moreover, the increasing prevalence of CVD drives the growth of the market. According to a BioMed Central Ltd article published in December 2024, in the UAE, the age-standardized cardiovascular disease (CVD) prevalence was estimated at around 11,066.8 cases per 100,000 population, marking the highest rate in North Africa and the Middle East. This significant disease burden underscores a substantial demand for advanced cardiovascular devices to support early diagnosis, effective treatment, and long-term management of heart-related conditions. The high prevalence rate reflects the growing need for innovative medical technologies, such as minimally invasive surgical tools, advanced monitoring systems, and next-generation implantable devices, to address the escalating cardiovascular health challenges within the country.

UAE Cardiovascular Devices Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the UAE cardiovascular devices market report based on product, distribution channel, and end use:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic & Monitoring
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
  • MRI
  • Cardiovascular Ultrasound
  • 2D
  • 3D/4D
  • Doppler
  • Cardiac Diagnostic Catheters
  • PET Scanner
  • Surgical Devices
  • Cardiac Resynchronization Therapy (CRT)
  • Implantable Cardioverter Defibrillators (ICDs)
  • Pacemakers
  • Coronary Stents
  • Catheters
  • Guidewires
  • Cannula
  • Valves
  • Occlusion Devices
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online
  • Offline
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Distribution Channel
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Segment
2.2.2. Distribution Channel Segment
2.2.3. End Use Segment
2.3. Competitive Insights
Chapter 3. UAE Cardiovascular Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of cardiovascular diseases (CVDs)
3.2.1.2. Increasing awareness and screening programs
3.2.1.3. Rising government initiatives for the CVD
3.2.1.4. Technological advancement in CVD devices
3.2.2. Market restraint analysis
3.2.2.1. High costs associated with the devices
3.2.2.2. Product recalls in UAE
3.3. UAE Cardiovascular Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. UAE Cardiovascular Devices Market: Product Estimates & Trend Analysis
4.1. UAE Cardiovascular Devices Market: Product Dashboard
4.2. UAE Cardiovascular Devices Market: Product Movement Analysis
4.3. UAE Cardiovascular Devices Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Diagnostic & Monitoring
4.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.2. ECG
4.4.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.3. Implantable Cardiac Monitors
4.4.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.4. Holter Monitors
4.4.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.5. Mobile Cardiac Telemetry
4.4.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.6. MRI
4.4.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.7. Cardiovascular Ultrasound
4.4.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.8. Cardiac Diagnostic Catheters
4.4.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.4.9. PET Scanner
4.4.9.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5. Surgical Devices
4.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.2. Cardiac Resynchronization Therapy (CRT)
4.5.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.3. Implantable Cardioverter Defibrillators (ICDs)
4.5.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.4. Pacemakers
4.5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.5. Coronary Stents
4.5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.6. Catheters
4.5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.7. Guidewires
4.5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.8. Cannula
4.5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.9. Valves
4.5.9.1. Market estimates and forecast 2021 - 2033 (USD Million)
4.5.10. Occlusion Devices
4.5.10.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 5. UAE Cardiovascular Devices Market: Distribution Channel Estimates & Trend Analysis
5.1. UAE Cardiovascular Devices Market: Distribution Channel Dashboard
5.2. UAE Cardiovascular Devices Market: Distribution Channel Movement Analysis
5.3. UAE Cardiovascular Devices Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 - 2033 (USD Million)
5.4. Online
5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5. Offline
5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 6. UAE Cardiovascular Devices Market: End Use Estimates & Trend Analysis
6.1. UAE Cardiovascular Devices Market: End Use Dashboard
6.2. UAE Cardiovascular Devices Market: End Use Movement Analysis
6.3. UAE Cardiovascular Devices Market Size & Forecasts and Trend Analysis, by End Use, 2021 - 2033 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
6.6. Diagnostic Centers
6.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
6.7. Others
6.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2024
7.3.4. Abbott
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. GE HealthCare
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Edwards Lifesciences Corporation
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Siemens Healthineers AG
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Canon Medical Systems
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. B. Braun SE
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. LivaNova, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Cardinal Health
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Medtronic
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Boston Scientific Corporation
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. W. L. Gore & Associates, Inc.
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. BIOTRONIK SE & Co. KG
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.